基本信息
views: 303
Career Trajectory
Bio
For more than 30 years, Dr. Fox has directed his research efforts at improving the effectiveness of cancer immunotherapy. An expert in tumor immunology and immune profiling, he leads the Laboratory of Molecular and Tumor Immunology and provides oversight for the Biospecimen Repository, a core facility available to all investigators of the Earle A. Chiles Research Institute. Additionally, he is an associate professor in Molecular Microbiology and Immunology at Oregon Health and Science University, and is a co-leader of the Tumor Immunology Focus Panel for the Knight Cancer Institute.
Dr. Fox’s background in translational cancer immunotherapy developed from his tenure as a fellow in Dr. Steven Rosenberg’s lab at the National Cancer Institute, a part of the National Institutes for Health. His research efforts are divided between preclinical models, the development, performance, and monitoring of cancer immunotherapy trials, and the training of the next generation of translational investigators. He has served on review committees for the NIH, FDA, philanthropic and governmental organizations in the United States, Europe and Asia. He serves on editorial boards of seven scientific journals, lectures widely, consults for the biotechnology and pharmaceutical sectors, and is an internationally recognized expert on cancer immunotherapy.
Dr. Fox is past president of the Society for Immunotherapy of Cancer and is current chair of the World Immunotherapy Council, a consortium of 22 national and international cancer immunotherapy organizations. He also serves on the Board of Directors of the Oregon Bioscience Association.
Memberships
American Association for Advancement of Science
American Association for Cancer Research
American Association of Immunologists
American Society of Clinical Oncology
Society for Immunotherapy of Cancer
Honors and Awards
Extraordinary Service to Society Award, Society for Immunotherapy of Cancer (SITC), 2020
Member, SITC COVID-19 Response Task Force, 2020-present
Member, Cellular, Tissue, and Gene Therapies Advisory Committee, US FDA, 2020-present
Chair, Scientific Advisory Board, Marseille Immunopole, French National Science
Agency/European Union NSCLC Immunotherapy Program, 2019-2024
Council Member, American Cancer Society, 2015-2018
Board of Directors, Oregon Bioscience Association, 2014-present
External Advisory Board, Karmanos Cancer Institute, Wayne State University, Detroit, MI, 2014-2016
Section Editor, Journal for Immunotherapy of Cancer, SITC official Journal, 2013-2016
Scientific Advisory Board, McMasters Immunology Research Centre, Hamilton, Ontario, 2012-2015
Chair, SITC Global Colon Cancer Immunoscore Taskforce / Steering Committee, 2012-present
Chair, World Immunotherapy Council (WIC), 2011-present
Editorial Board, OncoImmunology and International Journal of Oncology, 2011-present
Executive Council, Society for Immunotherapy of Cancer (SITC), 2010-present
External Advisory Board, Vaccine Branch, Center for Cancer Research, NCI, NIH, 2009-present
Editorial Board, Tumor Immunology and Biological Cancer Therapy, iSBTc/SITC section of the Journal of Translational Medicine, 2009-present
External Scientific Advisory Board, Hollings Cancer Center, Medical University of S.C., 2009-2013
President, SITC, 2008-2010
Vice President/President Elect, SITC, 2006-2008
Treasurer, SITC, 2005-2006
Co-founder and Managing Member/CEO, UbiVac, 2005-present
Member, Cancer Immunopathology and Immunotherapy (CII) Study Section NCI, NIH, 2003-2005
Editorial Board, Journal of Immunotherapy, 2003-present
Board of Directors, International Society for the Biological Therapy of Cancer (iSBTc), 2002-2005
Member, Experimental Therapeutics II (ETII) Study Section NCI, NIH, 2002-2003
Guest Professor, Xi’an Jiaotong University, Xi’an, China, 2001-2010
Editorial Board, Expert Opinion on Biological Therapy, 2001-present
Visiting Professor Award, Chiles Foundation, 2001 – 2002
Guest Professor Award, Der Deutsche Akademische Austausch Dienst, 2001 – 2002
Editorial Board – Cellular Immunology and Current Molecular Medicine, 2000-present
Science Recognition Award for New Investigators, Clinical Immunology Society,1990
Travel Grant, 7th Int’l Immunology Congress, American Association of Immunology, 1989
Dr. Fox’s background in translational cancer immunotherapy developed from his tenure as a fellow in Dr. Steven Rosenberg’s lab at the National Cancer Institute, a part of the National Institutes for Health. His research efforts are divided between preclinical models, the development, performance, and monitoring of cancer immunotherapy trials, and the training of the next generation of translational investigators. He has served on review committees for the NIH, FDA, philanthropic and governmental organizations in the United States, Europe and Asia. He serves on editorial boards of seven scientific journals, lectures widely, consults for the biotechnology and pharmaceutical sectors, and is an internationally recognized expert on cancer immunotherapy.
Dr. Fox is past president of the Society for Immunotherapy of Cancer and is current chair of the World Immunotherapy Council, a consortium of 22 national and international cancer immunotherapy organizations. He also serves on the Board of Directors of the Oregon Bioscience Association.
Memberships
American Association for Advancement of Science
American Association for Cancer Research
American Association of Immunologists
American Society of Clinical Oncology
Society for Immunotherapy of Cancer
Honors and Awards
Extraordinary Service to Society Award, Society for Immunotherapy of Cancer (SITC), 2020
Member, SITC COVID-19 Response Task Force, 2020-present
Member, Cellular, Tissue, and Gene Therapies Advisory Committee, US FDA, 2020-present
Chair, Scientific Advisory Board, Marseille Immunopole, French National Science
Agency/European Union NSCLC Immunotherapy Program, 2019-2024
Council Member, American Cancer Society, 2015-2018
Board of Directors, Oregon Bioscience Association, 2014-present
External Advisory Board, Karmanos Cancer Institute, Wayne State University, Detroit, MI, 2014-2016
Section Editor, Journal for Immunotherapy of Cancer, SITC official Journal, 2013-2016
Scientific Advisory Board, McMasters Immunology Research Centre, Hamilton, Ontario, 2012-2015
Chair, SITC Global Colon Cancer Immunoscore Taskforce / Steering Committee, 2012-present
Chair, World Immunotherapy Council (WIC), 2011-present
Editorial Board, OncoImmunology and International Journal of Oncology, 2011-present
Executive Council, Society for Immunotherapy of Cancer (SITC), 2010-present
External Advisory Board, Vaccine Branch, Center for Cancer Research, NCI, NIH, 2009-present
Editorial Board, Tumor Immunology and Biological Cancer Therapy, iSBTc/SITC section of the Journal of Translational Medicine, 2009-present
External Scientific Advisory Board, Hollings Cancer Center, Medical University of S.C., 2009-2013
President, SITC, 2008-2010
Vice President/President Elect, SITC, 2006-2008
Treasurer, SITC, 2005-2006
Co-founder and Managing Member/CEO, UbiVac, 2005-present
Member, Cancer Immunopathology and Immunotherapy (CII) Study Section NCI, NIH, 2003-2005
Editorial Board, Journal of Immunotherapy, 2003-present
Board of Directors, International Society for the Biological Therapy of Cancer (iSBTc), 2002-2005
Member, Experimental Therapeutics II (ETII) Study Section NCI, NIH, 2002-2003
Guest Professor, Xi’an Jiaotong University, Xi’an, China, 2001-2010
Editorial Board, Expert Opinion on Biological Therapy, 2001-present
Visiting Professor Award, Chiles Foundation, 2001 – 2002
Guest Professor Award, Der Deutsche Akademische Austausch Dienst, 2001 – 2002
Editorial Board – Cellular Immunology and Current Molecular Medicine, 2000-present
Science Recognition Award for New Investigators, Clinical Immunology Society,1990
Travel Grant, 7th Int’l Immunology Congress, American Association of Immunology, 1989
Research Interests
Papers共 479 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tara Muijlwijk, Dennis N. L. M. Nijenhuis,Sonja H. Ganzevles,Arjen Brink, Changlin Ke,Joseph N. Fass,Venkatesh Rajamanickam,C. Rene Leemans,Yoshinobu Koguchi,Bernard A. Fox,Jos B. Poell,Ruud H. Brakenhoff,
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1 (2024)
Cancer Researchno. 7_Supplement (2024)
CANCER RESEARCHno. 7 (2024)
David A. Knorr,Lucas Blanchard,Rom S. Leidner,Shawn M. Jensen,Ryan Meng, Andrew Jones,Carmen Ballesteros-Merino,Richard B. Bell,Maria Baez, Alessandra Marino,David Sprott,Carlo B. Bifulco,
crossref(2024)
EUROPEAN JOURNAL OF CANCER (2024): 113501-113501
David A. Knorr,Lucas Blanchard,Rom S. Leidner,Shawn M. Jensen,Ryan Meng,Andrew Jones,Carmen Ballesteros-Merino, Richard B. Bell,Maria Baez, Alessandra Marino,David Sprott,Carlo B. Bifulco,
CANCER IMMUNOLOGY RESEARCHno. 3 (2024): 322-333
crossref(2023)
biorxiv(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn